Waikato Hospital is a major regional hospital in Hamilton, New Zealand. It provides specialised and emergency healthcare for the Midlands and Waikato area with patients referred there from feeder hospitals like Whakatāne, Lakes area, Tauranga, Thames, Tokoroa and Rotorua.

There are 673 beds in Waikato District Health Board.

During the past decade, Waikato District Health Board conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 2 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 1 clinical trials were completed. i.e. 33.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Waikato District Health Board" #1 sponsor was "Proacta, Incorporated" with 3 trials, followed by "Gilead Sciences" with 2 trials sponsored, "Antisoma Research" with 1 trials sponsored, "Baxter Healthcare Corporation" with 1 trials sponsored and "Fisher and Paykel Healthcare" with 1 trials sponsored. Other sponsors include 3 different institutions and companies that sponsored additional 13 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Waikato District Health Board" #1 collaborator was "American College of Rheumatology" with 1 trials as a collaborator, "Applied Health Research Centre" with 1 trials as a collaborator, "Cambridge University Hospitals NHS Foundation Trust" with 1 trials as a collaborator, "Cancer Trials New Zealand" with 1 trials as a collaborator and "Counties Manukau Health" with 1 trials as a collaborator. Other collaborators include 0 different institutions and companies that were collaborators in the rest 10 trials.

According to Clinical.Site data, the most researched conditions in "Waikato District Health Board" are "Unspecified Adult Solid Tumor, Protocol Specific" (2 trials), "Aortic Aneurysm, Abdominal" (1 trials), "Arterial Thrombosis" (1 trials), "Bladder Cancer" (1 trials) and "Chronic HBV Infection" (1 trials). Many other conditions were trialed in "Waikato District Health Board" in a lesser frequency.

Most popular intervention types in "Waikato District Health Board" are "Drug" (10 trials), "Device" (3 trials), "Other" (1 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "PR104" (2 trials), "AS1409" (1 trials), "Dianeal" (1 trials), "Endurant Stent Graft" (1 trials) and "Extraneal" (1 trials). Other intervention names were less common.

The vast majority of trials in "Waikato District Health Board" are 16 trials for "All" genders.

Currently, there are NaN active trials in "Waikato District Health Board". 1 are not yet recruiting, 2 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 9 completed trials in Waikato District Health Board, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Waikato District Health Board, 4 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".

Waikato District Health Board has several departments that took part in Clinical trials: "Waikato Hospital; Dept of Medical Oncology" - 5 trials, "Waikato Hospital; Gastro Research" - 2 trials, "Waikato Hospital - Cancer and Blood Research Trials Unit; Regional Cancer Centre" - 2 trials